Status:
UNKNOWN
Evaluation of Tissue Glue on PICC and Midline Catheters Insertion Sites
Lead Sponsor:
University Hospital Ostrava
Conditions:
Adult Patients With Mid-term or Long-term Venous Access
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study will evaluate a new type of cyanoacrylate tissue glue Secure PortIV on the insertion site of the PICC (Peripherally inserted central catheter) or Midline catheters. Fixation of the catheter ...
Detailed Description
In the study, 125 subjects will receive the new tissue glue Secure PortIV and 125 subjects will be provided standard care. The tissue glue will be applied immediately after insertion. Evaluation and r...
Eligibility Criteria
Inclusion
- 18 years of age
- need of long-term venous access
- consent with participation in the study
Exclusion
- pediatric population
- not signing the informed consent form
Key Trial Info
Start Date :
May 4 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04900740
Start Date
May 4 2021
End Date
December 1 2024
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ostrava
Ostrava, Moravian-Silesian Region, Czechia, 708 52